HeartSciences Inc.HH

HeartSciences Inc.

0.0528USDR
−0.0092−14.84%
At close at Jun 6, 14:21 GMT
USD
No trades
See on Supercharts
Market capitalization
‪3.87 M‬USD
−10.2095USD
‪−6.61 M‬USD
‪18.60 K‬USD
‪979.57 K‬
Beta (1Y)
−1.03

About HeartSciences Inc.


CEO
Andrew Christopher Simpson
Headquarters
Southlake
Founded
2008
FIGI
BBG0185L9036
HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
Performance
‪−11,200.0%‬
‪−10,900.0%‬
‪−10,600.0%‬
‪−10,300.0%‬
‪−10,000.0%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.70 M‬‬
‪‪−1.80 M‬‬
‪‪−900.00 K‬‬
‪0.00‬
‪‪900.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Jul 2, 2025
2021
2022
2023
2024
‪−160.00‬
‪−120.00‬
‪−80.00‬
‪−40.00‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Displays a symbol's price movements over previous years to identify recurring trends.